Showing results (121-130 of 338) with videos related to

Sort By:
Pageof 34
Journal of Theoretical Biology|April 29, 2014
Modeling rates of infection with transient maternal antibodies and waning active immunity: application to Bordetella pertussis in SwedenZhilan Feng, John W Glasser, Andrew N Hill, et al.
The Pediatric Infectious Disease Journal|January 15, 2010
Immune response and one-year antibody persistence after a fourth dose of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine (HibMenCY) at 12 to 15 months of ageGary S Marshall, Colin D Marchant, Mark Blatter, et al.
The Pediatric Infectious Disease Journal|February 12, 2009
The impact of childhood meningococcal serogroup C conjugate vaccine programs in CanadaJulie A Bettinger, David W Scheifele, Nicole Le Saux, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|March 2, 2012
Heterogeneity of rotavirus testing and admitting practices for gastroenteritis among 12 tertiary care pediatric hospitals: Implications for surveillanceJulie A Bettinger, Kathryn Wills, Nicole Le Saux, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2002
Carotid artery dissection as a possible severe complication of pertussis in an adult: clinical case report and reviewDanuta M Skowronski, Jane A Buxton, Morris Hestrin, et al.
The Pediatric Infectious Disease Journal|August 29, 2012
The disease burden of invasive meningococcal serogroup B disease in CanadaJulie A Bettinger, David W Scheifele, Nicole Le Saux, et al.
Journal of the Pediatric Infectious Diseases Society|December 12, 2018
Burden of Children Hospitalized With Pertussis in Canada in the Acellular Pertussis Vaccine Era, 1999-2015Bahaa Abu-Raya, Julie A Bettinger, Otto G Vanderkooi, et al.
Vaccine|October 21, 2006
Phase 1 first-in-human studies of the reactogenicity and immunogenicity of a recombinant meningococcal NspA vaccine in healthy adultsScott A Halperin, Joanne M Langley, Bruce Smith, et al.
The Pediatric Infectious Disease Journal|May 1, 2007
Immunologic considerations for the timing of the booster dose of 7-valent pneumococcal conjugate vaccine in young childrenDavid W Scheifele, Scott A Halperin, Jan J Ochnio, et al.
Lancet Regional Health. Americas|November 29, 2023
Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of Respiratory Syncytial Virus disease among infants in Canada: a simulation studyAffan Shoukat, Elaheh Abdollahi, Alison P Galvani, et al.
Pageof 34